• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 4
  • 3
  • 1
  • 1
  • 1
  • 1

PRICE

7
7
7
10

PUBLISHED

0
1
1
10

PRODUCT TYPE

7
3

Search "VIRxSYS Corporation-Deals & Alliances Report" returned 10 results.

PRODUCT TITLE
VIRxSYS Corporation - Strategic SWOT Analysis Review VIRxSYS Corporation - Strategic SWOT Analysis Review - Product Thumbnail Image

VIRxSYS Corporation - Strategic SWOT Analysis Review

VIRxSYS Corporation - Strategic SWOT Analysis Review Summary VIRxSYS Corporation (VIRxSYS) is a privately held biotechnology company principally engaged in the development of gene based therapies...

February 2012
FROM

VIRxSYS Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

HIV / AIDS – Pipeline Review, H1 2013

Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline This report provides information on the therapeutic development for HIV...

February 2013
FROM
HIV / AIDS - Pipeline Review, H2 2012 HIV / AIDS - Pipeline Review, H2 2012 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H2 2012

HIV / AIDS – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H2 2012', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information...

August 2012
FROM
Viral Infections - Pipeline Review, H2 2012 Viral Infections - Pipeline Review, H2 2012 - Product Thumbnail Image

Viral Infections - Pipeline Review, H2 2012

Viral Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Viral Infections - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...

September 2012
FROM
HIV / AIDS - Pipeline Review, H1 2012 HIV / AIDS - Pipeline Review, H1 2012 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2012

HIV / AIDS – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2012', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information...

February 2012
FROM

Sangamo BioSciences, Inc. (SGMO) - Financial and Strategic SWOT Analysis Review

Sangamo BioSciences, Inc. (SGMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

May 2014
FROM

HIV / AIDS - Pipeline Review, H2 2011

HIV / AIDS - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H2 2011', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information...

September 2011
FROM

HIV / AIDS - Pipeline Review, Q1 2011

HIV / AIDS - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, Q1 2011', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information...

February 2011
FROM

HIV / AIDS - Pipeline Review, Q4 2010

HIV / AIDS - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “HIV and Aids Pipeline Review, Q4 2010”, provides an overview of the HIV and Aids therapeutic pipeline. This report provides...

December 2010
FROM
Loading Indicator